|
1
|
Nam S, Chung JW and Yang JY: WNT5A
correlates with clinicopathological characteristics in gastric
cancer: A meta-analysis. Cell Physiol Biochem. 41:33–40. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Liu J, Zhang G and Kong D:
Individualized proximal margin correlates with outcomes in gastric
cancers with radical gastrectomy. Tumour Biol.
39:10104283177110322017.PubMed/NCBI
|
|
3
|
Kim DH, Kim SM, Choi MG, Sohn TS, Bae JM
and Kim S: Multiple primary malignancies in patients with multiple
early gastric cancer. J Gastric Cancer. 17:154–161. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Son T, Kwon IG, Lee JH, Choi YY, Kim HI,
Cheong JH, Noh SH and Hyung WJ: Impact of splenic hilar lymph node
metastasis on prognosis in patients with advanced gastric cancer.
Oncotarget. Jun 28–2017.(Epub ahead of print).
|
|
5
|
Gui R, Tang H, Gao M, Liu J, Huang R, Zhao
G, Ma J, Yi M, Liu F and Fu Y: Impact of perioperative blood
transfusion on survival of patients undergoing laparoscopic
gastrectomy for gastric cancer. J BUON. 22:396–402. 2017.PubMed/NCBI
|
|
6
|
Yu B and Xie J: Identifying therapeutic
targets in gastric cancer: The current status and future direction.
Acta Biochim Biophys Sin (Shanghai). 48:90–96. 2016.PubMed/NCBI
|
|
7
|
Spychała A, Nowaczyk P and Murawa D:
Comparison of lymphatic system staging classifications in patients
with gastric cancer. Pol Przegl Chir. 87:551–557. 2015.PubMed/NCBI
|
|
8
|
Qiu MZ, Wang ZQ, Zhang DS, Luo HY, Zhou
ZW, Wang FH, Li YH, Jiang WQ and Xu RH: Clinicopathological
characteristics and prognostic analysis of gastric cancer in the
young adult in China. Tumour Biol. 32:509–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petrelli F, Ghidini M, Barni S,
Steccanella F, Sgroi G, Passalacqua R and Tomasello G: Prognostic
role of primary tumor location in non-metastatic gastric cancer: A
systematic review and meta-analysis of 50 studies. Ann Surg Oncol.
24:2655–2668. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costa LB, Toneto MG and Moreira LF: Do
proximal and distal gastric tumours behave differently? Arq Bras
Cir Dig. 29:232–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ahmad R, Setia N, Schmidt BH, Hong TS, Wo
JY, Kwak EL, Rattner DW, Lauwers GY and Mullen JT: Predictors of
lymph node metastasis in western early gastric cancer. J
Gastrointest Surg. 20:531–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JH, Kang JW, Nam BH, Cho GS, Hyung WJ,
Kim MC, Lee HJ, Ryu KW, Ryu SW, Shin DW, et al: Correlation between
lymph node count and survival and a reappraisal of lymph node ratio
as a predictor of survival in gastric cancer: A multi-institutional
cohort study. Eur J Surg Oncol. 43:432–439. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JJ, Song KY, Hur H, Hur JI, Park SM
and Park CH: Lymph node micrometastasis in node negative early
gastric cancer. Eur J Surg Oncol. 35:409–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nitti D, Marchet A, Olivieri M, Ambrosi A,
Mencarelli R, Belluco C and Lise M: Ratio between metastatic and
examined lymph nodes is an independent prognostic factor after D2
resection for gastric cancer: Analysis of a large European
monoinstitutional experience. Ann Surg Oncol. 10:1077–1085. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kunisaki C, Makino H, Takagawa R, Oshima
T, Nagano Y, Kosaka T, Ono HA, Otsuka Y, Akiyama H, Ichikawa Y, et
al: Tumor diameter as a prognostic factor in patients with gastric
cancer. Ann Surg Oncol. 15:1959–1967. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ren K, Liu QQ, An ZF, Zhang DP and Chen
XH: MiR-144 functions as tumor suppressor by targeting PIM1 in
gastric cancer. Eur Rev Med Pharmacol Sci. 21:3028–3037.
2017.PubMed/NCBI
|
|
17
|
Sano T, Coit DG, Kim HH, Roviello F,
Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new
stage grouping of gastric cancer for TNM classification:
International Gastric Cancer Association staging project. Gastric
Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tokunaga M, Ito S, Yoshikawa T, Nunobe S,
Fukagawa T, Misawa K, Cho H, Katai H, Sano T and Terashima M:
Prognostic factors for survival in patients with pT1 N+
or T2-3 N0 gastric cancer in Japan. Br J Surg. 104:885–890. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wen T, Wang Z, Li Y, Li Z, Che X, Fan Y,
Wang S, Qu J, Yang X, Hou K, et al: A Four-Factor immunoscore
system that predicts clinical outcome for stage II/III gastric
cancer. Cancer Immunol Res. 5:524–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Zhang X, Hu J, Zeng W and Zhou Z:
Clinicopathological features and outcomes in patients undergoing
radical resection for early gastric cancer with signet ring cell
histology. J Visc Surg. 152:357–361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang
XK, Luo RZ, Yun JP, Xie D, Li YF, et al: The prognostic
significance of lymphovascular invasion in patients with resectable
gastric cancer: A large retrospective study from Southern China.
BMC Cancer. 15:3702015. View Article : Google Scholar : PubMed/NCBI
|
